Perspectives on cancer chemoprevention research and drug development

Advances in Cancer Research

Volumn 78, Issue , 1999, Pages 320-334

  Kelloff, Gary J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIESTROGEN; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIMUTAGENIC AGENT; ANTIOXIDANT; AROMATASE INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH INHIBITOR; HORMONE INHIBITOR; LIPOXYGENASE INHIBITOR; NITRIC OXIDE SYNTHASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; POLYPHENOL; PROTEIN INHIBITOR; RETINOID; SELENIUM;

CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RESEARCH; CARCINOGENESIS; CHEMOPROPHYLAXIS; DRUG EFFICACY; GENOTYPE; HUMAN; MITOGENESIS; MUTAGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TARGET ORGAN; TISSUE SPECIFICITY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; AROMATASE INHIBITORS; CLINICAL TRIALS; ESTROGEN RECEPTOR MODULATORS; GENES, RAS; HUMANS; NEOPLASMS; PROTEIN ISOPRENYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETINOIDS; SIGNAL TRANSDUCTION;

EID: 0032704372     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0065-230x(08)61026-x     Document Type: Article

References (4)

1. Ablin, R. J., and Shaw, M. W. (1986). Anticancer Res. 6, 327-328.
2. Albanes, D., Heinonen, O. P., Taylor, P. R., Virtamo, J., Edwards, B. K., Rautalahti, M., Hartman, A. M., Palmgren, J., Freedman, L. S., Haapakoski, J., Barrett, M. J., Pietinen, P., Malila, N., Tala, E., Liippo, K., Salomaa, E.-R., Tangrea, J. A., Teppo, L., Askin, F. B., Taskinenen, E., Erozan, Y., Greenwald, P., and Huttunen, J. K. (1996). J. Natl. Cancer Inst. 88, 1560-1570.
3. Anderson, K. M., Wygodny, J. B., Ondrey, F., and Harris, J. (1988). Prostate 12, 3-12.
4. Anderson, K. M., Levin, J., Jajeh, A., Seed, T., and Harris, J. E. (1993). Fatty Acids 48, 323-326.